duocarmycin sa has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmuck, K; Sieber, SA; Tietze, LF; Wirth, T | 1 |
Bringmann, G; Krewer, B; Magull, J; Major, F; Maksimenka, K; Schuberth, I; Spiegl, DA; Tietze, LF | 1 |
2 other study(ies) available for duocarmycin sa and Lung Neoplasms
Article | Year |
---|---|
Duocarmycin analogues target aldehyde dehydrogenase 1 in lung cancer cells.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents, Alkylating; Binding Sites; Cell Line, Tumor; Cell Proliferation; Duocarmycins; Humans; Indoles; Isoenzymes; Lung Neoplasms; Pyrroles; Recombinant Proteins; Retinal Dehydrogenase; Tandem Mass Spectrometry | 2012 |
Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Duocarmycins; Humans; Indoles; Inhibitory Concentration 50; Lung Neoplasms; Molecular Structure; Prodrugs; Pyrroles; Stereoisomerism | 2007 |